Drug Profile
Dengue DNA vaccine - Naval Medical Research Center/Fresh Tracks Therapeutics
Alternative Names: D1ME; Tetravalent dengue plasmid DNA vaccine - Naval Medical Research Center/Fresh Tracks Therapeutics; Tetravalent dengue vaccine - Naval Medical Research Center/Fresh Tracks Therapeutics; TVDVLatest Information Update: 25 Sep 2023
Price :
$50
*
At a glance
- Originator Naval Medical Research Center; Vical
- Developer Fresh Tracks Therapeutics; Naval Medical Research Center; United States Army Medical Research and Materiel Command; Walter Reed Army Institute of Research
- Class Dengue vaccines; Gene therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Dengue